Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-Masked, Parallel-Group, Randomized, Single-Dose Bioequivalence Study of Tobradex AF Suspension and TOBRADEX Ophthalmic Suspension

NCT00362895 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT00362895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00362895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-Masked, Parallel-Group, Randomized, Single-Dose Bioequivalence Study of Tobradex AF Suspension and TOBRADEX Ophthalmic Suspension
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
August 31, 2006
Enrollment
995 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cataract